PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DAVE vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DAVE and LLY is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

DAVE vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dave Inc. (DAVE) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%150.00%200.00%SeptemberOctoberNovemberDecember2025February
155.72%
-7.99%
DAVE
LLY

Key characteristics

Sharpe Ratio

DAVE:

2.79

LLY:

0.53

Sortino Ratio

DAVE:

3.67

LLY:

0.94

Omega Ratio

DAVE:

1.45

LLY:

1.12

Calmar Ratio

DAVE:

3.35

LLY:

0.67

Martin Ratio

DAVE:

14.91

LLY:

1.55

Ulcer Index

DAVE:

21.40%

LLY:

10.54%

Daily Std Dev

DAVE:

114.31%

LLY:

30.86%

Max Drawdown

DAVE:

-99.01%

LLY:

-68.27%

Current Drawdown

DAVE:

-77.95%

LLY:

-8.69%

Fundamentals

Market Cap

DAVE:

$1.28B

LLY:

$784.71B

EPS

DAVE:

$3.05

LLY:

$11.70

PE Ratio

DAVE:

33.08

LLY:

74.67

Total Revenue (TTM)

DAVE:

$246.24M

LLY:

$45.04B

Gross Profit (TTM)

DAVE:

$173.08M

LLY:

$36.76B

EBITDA (TTM)

DAVE:

$19.21M

LLY:

$15.63B

Returns By Period

In the year-to-date period, DAVE achieves a 16.08% return, which is significantly higher than LLY's 13.37% return.


DAVE

YTD

16.08%

1M

8.46%

6M

155.83%

1Y

327.91%

5Y*

N/A

10Y*

N/A

LLY

YTD

13.37%

1M

14.16%

6M

-7.99%

1Y

14.27%

5Y*

46.57%

10Y*

31.15%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DAVE vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DAVE
The Risk-Adjusted Performance Rank of DAVE is 9595
Overall Rank
The Sharpe Ratio Rank of DAVE is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of DAVE is 9595
Sortino Ratio Rank
The Omega Ratio Rank of DAVE is 9393
Omega Ratio Rank
The Calmar Ratio Rank of DAVE is 9696
Calmar Ratio Rank
The Martin Ratio Rank of DAVE is 9696
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 6363
Overall Rank
The Sharpe Ratio Rank of LLY is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 5858
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 5757
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 7373
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 6464
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DAVE vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Dave Inc. (DAVE) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DAVE, currently valued at 2.79, compared to the broader market-2.000.002.002.790.53
The chart of Sortino ratio for DAVE, currently valued at 3.67, compared to the broader market-4.00-2.000.002.004.006.003.670.94
The chart of Omega ratio for DAVE, currently valued at 1.45, compared to the broader market0.501.001.502.001.451.12
The chart of Calmar ratio for DAVE, currently valued at 3.35, compared to the broader market0.002.004.006.003.350.67
The chart of Martin ratio for DAVE, currently valued at 14.91, compared to the broader market-10.000.0010.0020.0030.0014.911.55
DAVE
LLY

The current DAVE Sharpe Ratio is 2.79, which is higher than the LLY Sharpe Ratio of 0.53. The chart below compares the historical Sharpe Ratios of DAVE and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.002.004.006.008.0010.0012.0014.00SeptemberOctoberNovemberDecember2025February
2.79
0.53
DAVE
LLY

Dividends

DAVE vs. LLY - Dividend Comparison

DAVE has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.62%.


TTM20242023202220212020201920182017201620152014
DAVE
Dave Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.62%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

DAVE vs. LLY - Drawdown Comparison

The maximum DAVE drawdown since its inception was -99.01%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for DAVE and LLY. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-77.95%
-8.69%
DAVE
LLY

Volatility

DAVE vs. LLY - Volatility Comparison

Dave Inc. (DAVE) has a higher volatility of 21.26% compared to Eli Lilly and Company (LLY) at 7.16%. This indicates that DAVE's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
21.26%
7.16%
DAVE
LLY

Financials

DAVE vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Dave Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab